Morana Jovan-Embiricos
CIK: 0001575745
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KLRS
Kalaris Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Jovan-Embiricos Morana
Jovan-Embiricos Morana (SEC CIK 0001575745) files insider reports with the SEC as Director of Kalaris Therapeutics, Inc. (KLRS).
Signal8 holds 2 ownership filings by Jovan-Embiricos Morana, all Form 4s, filed between Apr 11, 2025 and Jun 4, 2026. Those filings report 2 transactions, from Apr 10, 2025 to Jun 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Jovan-Embiricos Morana's filings is in BERKELEY HEIGHTS, NJ.
Recent filings by Jovan-Embiricos Morana
Other insiders filing for Kalaris Therapeutics, Inc. (KLRS)
- Vandekop Amy O'Leary, VP, Corporate Controller
- KEATING LAURIE, Director
- Bayko Liisa Ann, Chief Financial Officer
- Ferrara Napoleone, Director
- Hallal David, Director
- AKKARAJU SRINIVAS, Director